Gimme Care Alternative: Real Patient Complaints and Where to Switch

The complaints about Gimme Care are some of the most serious in the GLP-1 telehealth space — not just operational failures like slow shipping, but clinical failures that directly affect patient safety and treatment outcomes. Here is what patients have documented publicly.

Doctors prescribing the wrong dose — without ever talking to you

One of the most alarming patterns in Gimme Care complaints involves prescriptions written at doses that bear no relationship to what the patient actually needs — and doctors who refuse to correct them.

One patient had been on 12.5mg of tirzepatide when she signed up with Gimme for refills. Without speaking to her at all, a Gimme doctor wrote her a prescription for 2.2mg — claiming it was a “maintenance dose” based on her BMI. When she tried to reach the doctor, she got no response. After a three-hour wait, a customer service rep told her she would be charged $100 for the telehealth consultation — even though the doctor never spoke to her and wrote a prescription that would have set her treatment back by months.

Another patient, four months into treatment at 20 units, explicitly noted in her intake what dose she needed. The doctor prescribed the lowest starter dose of 4mg. Customer service blamed her for not communicating her dose — despite her having done exactly that. She lost $160 and received medication she could not use.

A third patient described receiving the same 1.5mg–3mg starter titration twice in a row — creating a cycle that would have her going from 1.5mg back down to 1.5mg within 8 weeks. When she pointed out the error, the doctor argued with her and insisted the prescription was correct. “These can’t be real doctors,” she wrote. “They’re idiots.”

No titration — same low dose for three months

Multiple patients report being prescribed the same low starting dose for an extended period with no upward titration — a red flag for anyone familiar with how GLP-1 medications actually work.

One patient who had previously been on semaglutide and was familiar with monthly dose increases was placed on the same dose for three full months. Zero appetite suppression. Zero weight loss. When she raised concerns, Gimme told her to increase her own dose using the medication she already had — which would obviously make it run out early. She finished the medication with no results and suspects the vials may have contained something other than tirzepatide. “I’m convinced I had a vial of saline,” she wrote.

Another patient explicitly asked Gimme to disclose what the medication was compounded with and the actual amounts of each ingredient. They never received an answer.

Medication arriving warm — and no accountability for it

Temperature integrity is non-negotiable for injectable GLP-1 medications. Multiple Gimme Care patients have reported receiving medication in packages where the ice had fully melted and the medication was warm on arrival.

When patients raised safety concerns, Gimme Care shifted responsibility to the compounding pharmacy rather than taking accountability. One patient requested lab reports or stability studies to confirm the medication was still safe — she received only shipping tracking information. Her access to the patient portal was later blocked, preventing any further communication. When she filed a BBB complaint, the agency reported the business as “unreachable or appeared to be out of business.”

No real support — everything through AI

A consistent complaint is the complete absence of real human support. There is no phone number that connects to a person. Chat support is AI-driven. Patients describe sending multiple messages over days or weeks with no meaningful response.

One patient described a situation where she ran out of medication after 21 days of no order, no tracking, and no response — eventually disputing three months of charges with her credit card company. Another wrote: “There is NO CUSTOMER SERVICE. I’ve gotten NO ANSWERS OR HELP. DONT USE GIMME CARE because they DONT CARE.”

The pattern across complaints is that when patients push back — on wrong doses, missing orders, or billing issues — communication stops. The only recourse most patients have found is filing a chargeback with their credit card company.

What responsible GLP-1 care looks like

Every failure documented above has a straightforward solution — it just requires a provider that actually builds their operations around patient outcomes rather than minimizing operational overhead:

• A real physician reviews your history before prescribing — not an algorithm that ignores your intake notes
• Dose decisions are made with you, not imposed without consultation
• Medication ships with proper cold-chain handling — and if it arrives compromised, the provider takes responsibility
• Lab documentation is available for patients who request it
• A human answers the phone — or at minimum responds within hours, not days
• Refunds do not require a chargeback — if you didn’t receive what you paid for, you get your money back

How Renlo is different

At Renlo, every intake is reviewed by a licensed U.S. physician who looks at your actual history before prescribing — including your previous doses if you have been on GLP-1 treatment before. Medication is dispensed by FDA-regulated U.S. compounding pharmacies with strict quality and cold-chain standards. If you are not approved for treatment, you receive a full refund. And if something goes wrong, you reach a real person who can actually resolve it.

Start a free assessment with Renlo — you only pay if a licensed provider approves your treatment.

---

This article references publicly documented patient reviews from Trustpilot, Reddit, and BBB filings. All accounts are paraphrased from publicly available sources. This is not medical advice.